Jan 22 2020
In a January 20, 2020 press release, Fritsma Factor sponsor Precision BioLogic Inc. announced the availability of its new CRYOcheck Chromogenic Factor VIII assay in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and the respective in-country regulatory authorities.
This assay offers a test range from 0–200% FVIII using one standard curve.
Comments (0)Bleeding Disorders
No comments here.